Literature DB >> 22777264

Lack of response to pulse cyclophosphamide in neuromyelitis optica: evaluation of 7 patients.

Denis B Bichuetti1, Enedina M Lobato Oliveira, Fernanda de Castro Boulos, Alberto A Gabbai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22777264     DOI： 10.1001/archneurol.2012.545

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  16 in total

Review 1.  Neuromyelitis optica spectrum disorders.

Authors:  Eoin P Flanagan; Brian G Weinshenker
Journal:  Curr Neurol Neurosci Rep       Date:  2014-09       Impact factor: 5.081

2.  [Therapeutic options for autoimmune encephalomyelitis].

Authors:  N Borisow; H Prüss; F Paul
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

Review 3.  Treatment of neuromyelitis optica: state-of-the-art and emerging therapies.

Authors:  Marios C Papadopoulos; Jeffrey L Bennett; Alan S Verkman
Journal:  Nat Rev Neurol       Date:  2014-08-12       Impact factor: 42.937

Review 4.  Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.

Authors:  Ingo Kleiter; Ralf Gold
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 5.  The treatment of neuromyelitis optica.

Authors:  Markus C Kowarik; John Soltys; Jeffrey L Bennett
Journal:  J Neuroophthalmol       Date:  2014-03       Impact factor: 3.042

6.  Intravenous Immunoglobulin Treatment for Recurrent Optic Neuritis.

Authors:  Burcu Altunrende; Gülden Akdal; Meltem Söylev Bajin; Aylin Yaman; Meryem Kocaslan; Mecbure Nalbantoğlu; Hülya Ertaşoğlu; Gülsen Akman
Journal:  Noro Psikiyatr Ars       Date:  2018-11-28       Impact factor: 1.339

7.  Acute and Chronic Management of Neuromyelitis Optica Spectrum Disorder.

Authors:  Elena Sherman; May H Han
Journal:  Curr Treat Options Neurol       Date:  2015-11       Impact factor: 3.598

Review 8.  Pediatric Neuromyelitis Optica Spectrum Disorders.

Authors:  Grace Y Gombolay; Tanuja Chitnis
Journal:  Curr Treat Options Neurol       Date:  2018-05-02       Impact factor: 3.972

Review 9.  Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).

Authors:  Corinna Trebst; Sven Jarius; Achim Berthele; Friedemann Paul; Sven Schippling; Brigitte Wildemann; Nadja Borisow; Ingo Kleiter; Orhan Aktas; Tania Kümpfel
Journal:  J Neurol       Date:  2013-11-23       Impact factor: 4.849

10.  Neuromyelitis optica presenting with relapses under treatment with natalizumab: a case report.

Authors:  De-Hyung Lee; Alexandra B Laemmer; Anne Waschbisch; Tobias Struffert; Christian Maihöfner; Stefan Schwab; Ralf Andreas Linker
Journal:  J Med Case Rep       Date:  2014-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.